| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Potassium Channels, Tandem Pore Domain | 5 | 2017 | 16 | 1.320 |
Why?
|
| Echocardiography | 12 | 2021 | 938 | 1.240 |
Why?
|
| Sodium | 3 | 2017 | 331 | 1.160 |
Why?
|
| Potassium Channels | 5 | 2011 | 343 | 1.150 |
Why?
|
| Practice Guidelines as Topic | 7 | 2019 | 1048 | 1.020 |
Why?
|
| Potassium Channels, Voltage-Gated | 4 | 2015 | 125 | 1.000 |
Why?
|
| Heart Ventricles | 9 | 2021 | 779 | 0.880 |
Why?
|
| Sumoylation | 3 | 2023 | 18 | 0.880 |
Why?
|
| SUMO-1 Protein | 2 | 2011 | 16 | 0.740 |
Why?
|
| Stroke Volume | 6 | 2021 | 465 | 0.740 |
Why?
|
| Neurons | 5 | 2023 | 1584 | 0.740 |
Why?
|
| Shal Potassium Channels | 2 | 2010 | 5 | 0.670 |
Why?
|
| Ventricular Dysfunction | 2 | 2015 | 28 | 0.620 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2016 | 5 | 0.570 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2017 | 200 | 0.570 |
Why?
|
| Heart Valve Diseases | 1 | 2017 | 115 | 0.530 |
Why?
|
| Aortic Valve Stenosis | 4 | 2019 | 144 | 0.520 |
Why?
|
| Aorta | 1 | 2017 | 288 | 0.520 |
Why?
|
| Echocardiography, Doppler | 4 | 2019 | 186 | 0.520 |
Why?
|
| Aorta, Thoracic | 2 | 2021 | 168 | 0.490 |
Why?
|
| Echocardiography, Three-Dimensional | 4 | 2021 | 516 | 0.490 |
Why?
|
| Algorithms | 5 | 2021 | 1884 | 0.480 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 111 | 0.460 |
Why?
|
| Aortic Diseases | 1 | 2015 | 102 | 0.460 |
Why?
|
| Cricetulus | 5 | 2016 | 127 | 0.430 |
Why?
|
| CHO Cells | 5 | 2016 | 188 | 0.430 |
Why?
|
| Potassium | 2 | 2011 | 255 | 0.430 |
Why?
|
| Ventricular Function, Left | 3 | 2021 | 607 | 0.400 |
Why?
|
| Myocytes, Cardiac | 2 | 2015 | 314 | 0.390 |
Why?
|
| Hypokalemia | 1 | 2011 | 23 | 0.390 |
Why?
|
| Hypoxia | 1 | 2016 | 653 | 0.390 |
Why?
|
| Shab Potassium Channels | 1 | 2011 | 29 | 0.380 |
Why?
|
| Image Enhancement | 2 | 2017 | 567 | 0.380 |
Why?
|
| Xenopus laevis | 5 | 2009 | 138 | 0.370 |
Why?
|
| Aortic Valve | 3 | 2019 | 244 | 0.360 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2010 | 9 | 0.360 |
Why?
|
| Rats | 6 | 2016 | 4043 | 0.360 |
Why?
|
| Societies, Medical | 7 | 2017 | 579 | 0.350 |
Why?
|
| Kv1.3 Potassium Channel | 1 | 2009 | 14 | 0.350 |
Why?
|
| Mitral Valve Stenosis | 1 | 2010 | 38 | 0.350 |
Why?
|
| Scorpion Venoms | 1 | 2009 | 25 | 0.340 |
Why?
|
| Neurotoxins | 1 | 2009 | 49 | 0.340 |
Why?
|
| Potassium Channel Blockers | 1 | 2009 | 64 | 0.340 |
Why?
|
| Humans | 43 | 2021 | 89572 | 0.330 |
Why?
|
| Cell Membrane | 3 | 2010 | 675 | 0.330 |
Why?
|
| Biopolymers | 1 | 2009 | 26 | 0.320 |
Why?
|
| Protein Multimerization | 1 | 2010 | 177 | 0.320 |
Why?
|
| Peptides | 2 | 2009 | 648 | 0.320 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2008 | 11 | 0.310 |
Why?
|
| Animals | 18 | 2023 | 27419 | 0.310 |
Why?
|
| Catheterization | 1 | 2010 | 237 | 0.310 |
Why?
|
| Protein Subunits | 1 | 2008 | 123 | 0.300 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 101 | 0.300 |
Why?
|
| Membrane Potentials | 5 | 2015 | 436 | 0.300 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2019 | 53 | 0.300 |
Why?
|
| Hippocampus | 1 | 2011 | 448 | 0.290 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 96 | 0.290 |
Why?
|
| Oocytes | 4 | 2009 | 221 | 0.280 |
Why?
|
| Cricetinae | 4 | 2015 | 558 | 0.280 |
Why?
|
| Protein Biosynthesis | 1 | 2008 | 389 | 0.270 |
Why?
|
| Ion Channel Gating | 2 | 2006 | 329 | 0.260 |
Why?
|
| Sudden Infant Death | 1 | 2006 | 27 | 0.260 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 330 | 0.260 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2005 | 12 | 0.250 |
Why?
|
| Muscle Proteins | 1 | 2006 | 133 | 0.250 |
Why?
|
| Sodium Channels | 1 | 2006 | 130 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 689 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 512 | 0.240 |
Why?
|
| Europe | 5 | 2017 | 322 | 0.240 |
Why?
|
| Uterine Hemorrhage | 1 | 2004 | 21 | 0.230 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2016 | 136 | 0.230 |
Why?
|
| COS Cells | 3 | 2010 | 167 | 0.230 |
Why?
|
| Axon Initial Segment | 1 | 2023 | 2 | 0.220 |
Why?
|
| Female | 22 | 2021 | 46328 | 0.220 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2017 | 178 | 0.210 |
Why?
|
| Kidney | 1 | 2008 | 1147 | 0.210 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 3027 | 0.210 |
Why?
|
| Osteoblasts | 2 | 2013 | 98 | 0.200 |
Why?
|
| Amino Acid Sequence | 4 | 2009 | 2063 | 0.200 |
Why?
|
| Nursing Staff, Hospital | 1 | 2021 | 42 | 0.190 |
Why?
|
| Models, Molecular | 3 | 2009 | 1303 | 0.180 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 147 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 2664 | 0.180 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2021 | 89 | 0.170 |
Why?
|
| Ventricular Pressure | 1 | 2019 | 38 | 0.170 |
Why?
|
| Sensitivity and Specificity | 6 | 2017 | 2017 | 0.170 |
Why?
|
| Male | 16 | 2021 | 42514 | 0.170 |
Why?
|
| Ultrasonography, Interventional | 2 | 2010 | 124 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2884 | 0.160 |
Why?
|
| Heart Valve Prosthesis | 1 | 2019 | 98 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1225 | 0.160 |
Why?
|
| Brain | 1 | 2008 | 2289 | 0.150 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2017 | 7 | 0.140 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2017 | 25 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2019 | 298 | 0.140 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2017 | 22 | 0.140 |
Why?
|
| Ions | 1 | 2017 | 75 | 0.140 |
Why?
|
| Action Potentials | 2 | 2023 | 600 | 0.140 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 51 | 0.140 |
Why?
|
| Protein Conformation | 3 | 2009 | 892 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2763 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 2 | 2008 | 396 | 0.130 |
Why?
|
| Gene Deletion | 2 | 2015 | 344 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 740 | 0.130 |
Why?
|
| Electrophysiology | 2 | 2007 | 403 | 0.130 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2015 | 12 | 0.130 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2015 | 12 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2017 | 344 | 0.120 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 45 | 0.120 |
Why?
|
| Preoperative Care | 2 | 2017 | 395 | 0.120 |
Why?
|
| Vaginal Diseases | 1 | 2015 | 28 | 0.120 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2015 | 33 | 0.120 |
Why?
|
| Cerebellum | 1 | 2016 | 249 | 0.120 |
Why?
|
| United States | 7 | 2017 | 7013 | 0.120 |
Why?
|
| Menopause | 1 | 2015 | 76 | 0.120 |
Why?
|
| Cardiology | 1 | 2015 | 115 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 182 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2015 | 168 | 0.110 |
Why?
|
| Adult | 8 | 2021 | 26676 | 0.110 |
Why?
|
| Testosterone | 1 | 2015 | 276 | 0.110 |
Why?
|
| Mobile Applications | 1 | 2015 | 71 | 0.110 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2013 | 33 | 0.110 |
Why?
|
| Atrial Flutter | 1 | 2013 | 36 | 0.110 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 374 | 0.100 |
Why?
|
| Graft vs Host Disease | 1 | 2015 | 360 | 0.100 |
Why?
|
| Static Electricity | 2 | 2009 | 90 | 0.100 |
Why?
|
| Medicago truncatula | 1 | 2011 | 3 | 0.100 |
Why?
|
| Rhizobium | 1 | 2011 | 7 | 0.100 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2011 | 17 | 0.100 |
Why?
|
| Autophagy | 1 | 2013 | 159 | 0.100 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 6828 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 387 | 0.100 |
Why?
|
| Ion Transport | 1 | 2011 | 81 | 0.100 |
Why?
|
| Pericardiocentesis | 1 | 2010 | 4 | 0.090 |
Why?
|
| Heart Failure, Systolic | 1 | 2010 | 5 | 0.090 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 330 | 0.090 |
Why?
|
| Cardiac Catheterization | 1 | 2013 | 303 | 0.090 |
Why?
|
| Genome, Plant | 1 | 2011 | 96 | 0.090 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 20 | 0.090 |
Why?
|
| Blood Volume | 1 | 2010 | 49 | 0.090 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 96 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2011 | 42 | 0.090 |
Why?
|
| Lung Transplantation | 1 | 2015 | 292 | 0.090 |
Why?
|
| Catheter Ablation | 1 | 2013 | 253 | 0.090 |
Why?
|
| Optical Restriction Mapping | 1 | 2010 | 1 | 0.090 |
Why?
|
| Symbiosis | 1 | 2011 | 127 | 0.090 |
Why?
|
| Lysine | 1 | 2011 | 150 | 0.090 |
Why?
|
| Parathyroid Hormone | 1 | 2011 | 217 | 0.090 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 98 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2010 | 120 | 0.090 |
Why?
|
| Endometrium | 2 | 2015 | 50 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2011 | 269 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1527 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 162 | 0.090 |
Why?
|
| Computer Systems | 1 | 2010 | 79 | 0.090 |
Why?
|
| Peptide Library | 1 | 2009 | 84 | 0.090 |
Why?
|
| Electrodes, Implanted | 1 | 2010 | 182 | 0.080 |
Why?
|
| Mice | 5 | 2023 | 11787 | 0.080 |
Why?
|
| Drug Design | 1 | 2009 | 127 | 0.080 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2009 | 10 | 0.080 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 47 | 0.080 |
Why?
|
| Cell Line | 3 | 2011 | 2496 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 181 | 0.080 |
Why?
|
| Protein Engineering | 1 | 2009 | 141 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 713 | 0.080 |
Why?
|
| Mass Screening | 1 | 2013 | 637 | 0.080 |
Why?
|
| Models, Chemical | 1 | 2009 | 179 | 0.080 |
Why?
|
| Ligands | 1 | 2009 | 445 | 0.080 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2008 | 4 | 0.080 |
Why?
|
| Permeability | 1 | 2008 | 137 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 419 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 996 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 100 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 890 | 0.080 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 98 | 0.070 |
Why?
|
| Cell Survival | 1 | 2010 | 983 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1012 | 0.070 |
Why?
|
| Muscles | 1 | 2008 | 193 | 0.070 |
Why?
|
| Asparagine | 1 | 2007 | 30 | 0.070 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 486 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2007 | 96 | 0.070 |
Why?
|
| Biophysical Phenomena | 1 | 2007 | 124 | 0.070 |
Why?
|
| Rabbits | 1 | 2008 | 639 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2021 | 4309 | 0.070 |
Why?
|
| Biophysics | 1 | 2007 | 153 | 0.070 |
Why?
|
| Tryptophan | 1 | 2007 | 92 | 0.070 |
Why?
|
| Mexiletine | 1 | 2006 | 3 | 0.070 |
Why?
|
| Transfection | 1 | 2008 | 911 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 333 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 522 | 0.070 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2006 | 32 | 0.070 |
Why?
|
| Diastole | 2 | 2019 | 141 | 0.060 |
Why?
|
| Cytokines | 1 | 2009 | 804 | 0.060 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2006 | 65 | 0.060 |
Why?
|
| Lipids | 1 | 2007 | 272 | 0.060 |
Why?
|
| Aged | 6 | 2021 | 19217 | 0.060 |
Why?
|
| Protein Binding | 2 | 2009 | 1488 | 0.060 |
Why?
|
| Xenopus Proteins | 1 | 2005 | 35 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 56 | 0.060 |
Why?
|
| Genome, Human | 1 | 2010 | 792 | 0.060 |
Why?
|
| Prognosis | 3 | 2019 | 3792 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 501 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 88 | 0.060 |
Why?
|
| Metacarpus | 1 | 2004 | 5 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 413 | 0.060 |
Why?
|
| External Fixators | 1 | 2004 | 19 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2005 | 118 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2009 | 510 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2005 | 221 | 0.060 |
Why?
|
| Environment | 1 | 2006 | 223 | 0.060 |
Why?
|
| Premenopause | 1 | 2004 | 57 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2011 | 966 | 0.060 |
Why?
|
| Menorrhagia | 1 | 2004 | 26 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1226 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2004 | 130 | 0.050 |
Why?
|
| Pyramidal Cells | 1 | 2023 | 81 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1728 | 0.050 |
Why?
|
| Middle Aged | 5 | 2021 | 26044 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1845 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 3223 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 826 | 0.050 |
Why?
|
| Inservice Training | 1 | 2021 | 38 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2006 | 1863 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2004 | 712 | 0.050 |
Why?
|
| Heart Atria | 2 | 2013 | 281 | 0.040 |
Why?
|
| District of Columbia | 1 | 2019 | 20 | 0.040 |
Why?
|
| Biopsy | 1 | 2004 | 1185 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 94 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2021 | 244 | 0.040 |
Why?
|
| Infant | 1 | 2006 | 3165 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2006 | 2880 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2017 | 8266 | 0.040 |
Why?
|
| Observer Variation | 1 | 2019 | 612 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2019 | 9080 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 326 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2013 | 2003 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 2353 | 0.030 |
Why?
|
| Mortality | 1 | 2016 | 149 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2016 | 146 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 265 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2015 | 72 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1903 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2015 | 87 | 0.030 |
Why?
|
| Endometrial Hyperplasia | 1 | 2015 | 11 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1597 | 0.030 |
Why?
|
| Vulva | 1 | 2015 | 23 | 0.030 |
Why?
|
| Myeloablative Agonists | 1 | 2015 | 36 | 0.030 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2016 | 113 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2015 | 34 | 0.030 |
Why?
|
| Consensus | 1 | 2017 | 360 | 0.030 |
Why?
|
| Unrelated Donors | 1 | 2015 | 45 | 0.030 |
Why?
|
| Dyspareunia | 1 | 2015 | 22 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 139 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 114 | 0.030 |
Why?
|
| Siblings | 1 | 2015 | 111 | 0.030 |
Why?
|
| Placebos | 1 | 2015 | 214 | 0.030 |
Why?
|
| Atrophy | 1 | 2015 | 121 | 0.030 |
Why?
|
| Postmenopause | 1 | 2015 | 102 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 434 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2013 | 21 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 306 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 5505 | 0.030 |
Why?
|
| Vagina | 1 | 2015 | 174 | 0.030 |
Why?
|
| Mutation | 1 | 2005 | 4162 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3669 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 995 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 988 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 1069 | 0.030 |
Why?
|
| Endometrial Neoplasms | 1 | 2015 | 208 | 0.020 |
Why?
|
| Synteny | 1 | 2011 | 28 | 0.020 |
Why?
|
| Nitrogen Fixation | 1 | 2011 | 37 | 0.020 |
Why?
|
| Vitis | 1 | 2011 | 19 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2013 | 255 | 0.020 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2011 | 5 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2011 | 34 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2011 | 23 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2011 | 26 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 71 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 56 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 77 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 231 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2011 | 84 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1537 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 115 | 0.020 |
Why?
|
| Venous Pressure | 1 | 2010 | 11 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 91 | 0.020 |
Why?
|
| Heart Injuries | 1 | 2010 | 19 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 94 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1873 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 217 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1720 | 0.020 |
Why?
|
| Hydatidiform Mole | 1 | 2010 | 6 | 0.020 |
Why?
|
| Chest Pain | 1 | 2010 | 42 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 274 | 0.020 |
Why?
|
| Thoracic Injuries | 1 | 2010 | 38 | 0.020 |
Why?
|
| Thrombosis | 1 | 2013 | 302 | 0.020 |
Why?
|
| Hypotension | 1 | 2010 | 71 | 0.020 |
Why?
|
| Dyspnea | 1 | 2010 | 76 | 0.020 |
Why?
|
| Radiology Information Systems | 1 | 2010 | 79 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 524 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2013 | 428 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 795 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 106 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 887 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 1309 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 1989 | 32 | 0.020 |
Why?
|
| Decision Making | 1 | 2015 | 668 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 6341 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 1989 | 56 | 0.020 |
Why?
|
| Lung | 1 | 2015 | 1266 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2010 | 471 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1989 | 260 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 1989 | 192 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2010 | 278 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 1310 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 2447 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 2408 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 395 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 1117 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1601 | 0.020 |
Why?
|
| Uterine Neoplasms | 1 | 2010 | 247 | 0.020 |
Why?
|
| Curriculum | 1 | 2010 | 568 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 1100 | 0.020 |
Why?
|
| Polymethyl Methacrylate | 1 | 2004 | 13 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2565 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2010 | 1379 | 0.010 |
Why?
|
| Equipment Design | 1 | 2004 | 419 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 3027 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2004 | 477 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1679 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 9281 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2010 | 1048 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1989 | 33 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1989 | 100 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1989 | 131 | 0.000 |
Why?
|
| Dogs | 1 | 1989 | 704 | 0.000 |
Why?
|
| Heart Rate | 1 | 1989 | 498 | 0.000 |
Why?
|